The company in question is, Allergan plc (NYSE:AGN) currently with a stock price of 236.31 (-2.86% today). The market cap for Allergan plc is 93488.96, and is in the sector Healthcare, and Drugs – Generic industry. The target price for Allergan plc is 299.06. Currently Allergan plc is trading with a P/E of *TBA, and a forward P/E of 13.79. Average volume for Allergan plc is 3173.72 and so far today it is 6109400.
Performance in the last year for Allergan plc has been -22.77%. For EPS growth, Allergan plc has seen a growth of 23.00%, and is looking to grow in the next year to 22.45%. More long term stats show that EPS growth has been -50.40% over the last five years and could be 13.49% for the next five years. Allergan plc has seen sales growth quarter over quarter at -77.20%, with EPS growth quarter over quarter at 78.20%. The 20-day simple moving average is -3.13%, with the 200-day simple moving average coming to -10.96%.
Since the IPO date for Allergan plc on the 2/17/1993, Allergan plc has seen performance year to date to be -24.38%. With Allergan plc trading at 236.31, the dividend yield is *TBA, and the EPS is -6.14.
So could Allergan plc, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 6.08 and the P/B is at 1.3. The P/cash is 184.54, with P/free cash flow at 21.2.
Allergan plc ability to deal with debt shows that the current ratio is 1, and the quick ratio is 0.9. This is with long term debt/equity at 0.52, and total debt/equity at 0.56.
In terms of margins, Allergan plc has a gross margin of 78.70%, an operating margin of -17.50% and a profit margin of 28.20%.Payout ratio for Allergan plc is 0.00%. Return on assets come to 3.20% with return on investment coming to -1.30%.
Insider ownership for Allergan plc, is at 0.10% and institutional ownership comes to 87.30%. Outstanding shares are at 395.62. While shares float is 395.29. The float short is currently 1.34%, and short ratio is 1.67.